Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment is closed. Header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment,' and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note (Revision: v3.6.0) replacing the prior version (Revision: v3.5.5).SummaryDifference0.6%

- Check13 days agoChange DetectedA new revision tag v3.5.5 was added, replacing the previous v3.5.4, indicating a minor update to the study record's documentation.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision tag (v3.5.4) now appears on the page, indicating a minor update to the record's metadata. The substantive study details and eligibility criteria appear unchanged.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a site/version change rather than an update to the clinical trial record itself.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.